Novo Nordisk(US:NVO) Sou Hu Cai Jing·2025-07-29 23:54Group 1 - The S&P 500 index ended a six-day winning streak, while European stocks rose [1] - Novo Nordisk's stock dropped by 28% after the appointment of a new CEO and a downward revision of its annual guidance, with sales of the weight-loss drug Wegovy falling short of expectations [1] - Crude oil prices surged over 3%, with a peak increase of more than 4% during intraday trading [1] Group 2 - The U.S.-China trade talks are ongoing in Stockholm, with both sides aiming to extend the paused 24% tariffs and corresponding countermeasures for an additional 90 days [1] - The U.S. Commerce Secretary indicated that there is still much "bargaining" to be done with the EU, focusing on digital services tax and steel and aluminum tariffs [1] - The IMF has slightly raised its global economic growth forecast, along with improved economic outlooks for both the U.S. and China [1]